Our expertise in translational pharmacology

Inoviem offers translational target discovery and drug-target Mode of Action (MoA) based on proprietary label-free technologies, developed in a pathological and physiological environment, that uses human tissue.

Translational pharmacology expertise

Pre-clinical to clinical phases

Our innovative approach

Biomarkers, patient and therapeutic window

Advantages of approach

Save time and money

How we work with clients

Tailored methodologies and technologies 

Need Help